摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-硫代异氰酸戊酯 | 629-12-9

中文名称
1-硫代异氰酸戊酯
中文别名
1-戊基异硫氰酸酯;异硫氰酸戊酯;1-异硫代氰酸戊酯
英文名称
pentyl isothiocyanate
英文别名
n-pentyl isothiocyanate;1-isothiocyanatopentane
1-硫代异氰酸戊酯化学式
CAS
629-12-9
化学式
C6H11NS
mdl
MFCD00014444
分子量
129.226
InChiKey
SGHJUJBYMSVAJY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    95 °C
  • 密度:
    0.93
  • 闪点:
    32°C
  • LogP:
    3.06
  • 物理描述:
    Colourless to yellow liquid; Sharp green irritating aroma
  • 溶解度:
    Very slightly soluble in water; freely soluble in ether
  • 折光率:
    1.495-1.501
  • 保留指数:
    1077
  • 稳定性/保质期:
    远离氧化剂、水分、酒精和胺。

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    8
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    44.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    8
  • 危险类别码:
    R10
  • 危险品运输编号:
    3080
  • 包装等级:
    III
  • 危险类别:
    8
  • 安全说明:
    S26,S36/37/39
  • 储存条件:
    应将化学品存放在充满干燥惰性气体的容器中,并置于阴凉、干燥处。储存地点需加锁,钥匙由技术人员及其助手管理,以确保安全。请避免接触湿气和水分,并远离氧化剂及酸类物质。

SDS

SDS:b444b47bc64bea8728c9bb79fd0bd72b
查看
Name: Pentyl isothiocyanate 95+% Material Safety Data Sheet
Synonym: n-Amylisothiocyanat
CAS: 629-12-9
Section 1 - Chemical Product MSDS Name:Pentyl isothiocyanate 95+% Material Safety Data Sheet
Synonym:n-Amylisothiocyanat

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
629-12-9 Pentyl isothiocyanate 95+% 211-075-6
Hazard Symbols: C
Risk Phrases: 20/21/22 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed. Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns. Lachrymator (substance which increases the flow of tears).
Skin:
Harmful if absorbed through the skin. Causes skin burns.
Ingestion:
Harmful if swallowed. Causes gastrointestinal tract burns.
Inhalation:
Harmful if inhaled. Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under nitrogen.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 629-12-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 117 - 119 deg C @70mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.93
Molecular Formula: C6H11NS
Molecular Weight: 129

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Bases, amines, strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 629-12-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Pentyl isothiocyanate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.*
Hazard Class: 8 (6.1)
UN Number: 2922
Packing Group: III
IMO
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.
Hazard Class: 8 (6.1)
UN Number: 2922
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE LIQUID, TOXIC, N.O.S.
Hazard Class: 8 (6.1)
UN Number: 2922
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 629-12-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 629-12-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 629-12-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    1-硫代异氰酸戊酯ammonium hydroxide 作用下, 以 为溶剂, 反应 16.0h, 以100%的产率得到1-pentylthiourea
    参考文献:
    名称:
    季巴比妥酸的催化不对称合成
    摘要:
    前手性巴比妥酸(假对称 1,3-二酰胺的一种亚型)的催化不对称 α-官能化产生相应的 5,5-二取代(季)衍生物基本上仍未解决。在这项研究中,2-烷硫基-4,6-二氧嘧啶被设计为关键的 1,3-二酰胺替代物,在胺-方酸酰胺催化的 CC 键形成反应中表现出色,乙烯基酮或 Morita-Baylis-Hillmann 型烯丙基溴作为亲电子试剂。加合物的温和酸水解以前所未有的对映选择性提供具有环内季碳的巴比妥酸衍生物,为生物学评估提供有价值的材料。
    DOI:
    10.1021/jacs.7b09124
  • 作为产物:
    描述:
    triethylamine pentylcarbamodithioate 在 双氧水 作用下, 以 四氢呋喃 为溶剂, 生成 1-硫代异氰酸戊酯
    参考文献:
    名称:
    脂肪族异硫氰酸酯类似物作为抗生素的合成及其构效关系
    摘要:
    异硫氰酸盐(ITC)是植物中发现的芥子油苷的多种分解产物之一,并且具有针对各种病原体的生物活性。在这项工作中,制备了脂族异硫氰酸酯,并测试了其对植物病原性真菌和细菌的抗菌活性,以了解其结构与活性之间的关系。结果表明施加空间抑制该长链衍生物关于对信托公司的毒性水稻纹枯病菌由于位阻和八个脂族的ITC的顺序为乙基>的 Ñ丙基>甲基>  ñ -己基>  Ñ辛基>  ñ -丁基> 正庚基>  n-戊基。由于ITC的疏水性通过增加烷基链长度而增强,因此ITC对胡萝卜欧文氏菌的抗菌活性中等,随着疏水性的增加而增强,其顺序为正辛基> 正戊基> 正庚基> 正己基>  n丙基> 正丁基>甲基>乙基。目前的研究表明,一些化合物表现出令人信服的抗菌活性,可以作为控制茄螺和胡萝卜螺的传统合成杀菌剂的可接受替代品。
    DOI:
    10.1007/s00044-012-0323-4
点击查看最新优质反应信息

文献信息

  • Novel pyridine derivative and pyrimidine derivative
    申请人:Matsushima Tomohiro
    公开号:US20050277652A1
    公开(公告)日:2005-12-15
    A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents C 1-6 alkyl or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents C 1-6 alkyl or the like; V 1 represents oxygen or the like; V 2 represents oxygen or sulfur; W represents —NH— or the like; X represents —CH═, nitrogen or the like; and Y represents oxygen or the like.]
    以下化合物的分子式,其盐或前述水合物具有出色的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抑制血管生成活性和抑制癌转移活性。 [R 1 代表C 1-6 烷基或类似物;R 2 和R 3 代表氢;R 4 ,R 5 ,R 6 和R 7 可以相同也可以不同,每个代表氢、卤素、C 1-6 烷基或类似物;R 8 代表氢或类似物;R 9 代表C 1-6 烷基或类似物;V 1 代表氧或类似物;V 2 代表氧或硫;W代表—NH—或类似物;X代表—CH═、氮或类似物;Y代表氧或类似物。]
  • Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
    申请人:Acharya A. Seetharama
    公开号:US20050159339A1
    公开(公告)日:2005-07-21
    The present invention provides pegylated hemoglobins comprising a thiocarbamoyl-phenyl-polyethylene glycol (PEG) attached to hemoglobin, and comprising a polyethylene glycol (PEG) attached to hemoglobin by an acyl group. The invention also provides methods of preparing pegylated hemoglobins using isothiocyanato phenyl carbamate of PEG and using isothiocyanato phenyl di-PEG carbamate. The invention further provides compositions and blood substitutes comprising pegylated hemoglobins and methods of treating a subject which comprise administering to the subject blood substitutes comprising non-hypertensive pegylated hemoglobins.
    本发明提供了包含硫代氨基甲酰基苯基聚乙二醇(PEG)连接到血红蛋白的聚乙二醇化血红蛋白,以及包含通过酰基连接到血红蛋白的聚乙二醇(PEG)的聚乙二醇化血红蛋白。该发明还提供了使用PEG的异硫氰酸苯基氨基甲酸酯和使用异硫氰酸苯基二PEG氨基甲酸酯制备聚乙二醇化血红蛋白的方法。该发明还提供了包含聚乙二醇化血红蛋白的组合物和血液替代品,以及治疗受试者的方法,包括向受试者施用包含非高血压聚乙二醇化血红蛋白的血液替代品。
  • Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
    申请人:——
    公开号:US20030229120A1
    公开(公告)日:2003-12-11
    Novel ligands for the HisB10 Zn 2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
    揭示了能够延长胰岛素制剂作用的R-态胰岛素六聚体的HisB10 Zn2+位点的新配体。
  • Heteroaryl compounds as P2Y1 receptor inhibitors
    申请人:Sutton C. James
    公开号:US20060173002A1
    公开(公告)日:2006-08-03
    The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y 1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y 1 receptor activity.
    本发明提供了新颖的杂环芳基化合物及其类似物,这些化合物是人类P2Y1受体的选择性抑制剂。该发明还提供了相应的各种药物组合物以及调节P2Y1受体活性治疗对其敏感的疾病的方法。
  • Aminobenzoxazoles as therapeutic agents
    申请人:Wishart Neil
    公开号:US20060025383A1
    公开(公告)日:2006-02-02
    A compound of Formula (I), wherein the substituents are as defined herein, which are useful as kinase inhibitors.
    其中取代基如本文所述的公式(I)的化合物,用作激酶抑制剂。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台